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Abstract. No evidence-based information exists to guide clinicians for giving presumptive treatment to returning
travelers when malaria is strongly suspected on clinical grounds but laboratory confirmation is not immediately available
or is negative. A prospective study was conducted in travelers or migrants who sought care for fever to identify clinical
and laboratory predictors of Plasmodium parasitemia. A total of 336 questionnaires were collected (97 malaria case
patients and 239 controls). Multivariate regression analysis showed inadequate prophylaxis, sweating, no abdominal
pain, temperature  38°C, poor general health, enlarged spleen, leucocytes  10 × 103/L, platelets < 150 × 103/L,
hemoglobin < 12 g/dL, and eosinophils 5% to be associated with parasitemia. Enlarged spleen had the highest positive
likelihood ratio for a diagnosis of malaria (13.6), followed by thrombopenia (11.0). Posttest probabilities for malaria
were 85% with enlarged spleen and 82% with thrombopenia. A rapid assessment can thus help to decide whether a
presumptive treatment should be given or not, especially when the results of the parasitological examination are not
immediately available or are uncertain.
INTRODUCTION
The diagnosis of malaria in nonendemic countries remains
a challenge. Improving the awareness and ability of doctors to
identify patients with a high probability of having malaria
should reduce severe morbidity and case fatality.1,2 Although
access to microscopic examination is easy in developed coun-
tries, the failure of physicians to think of malaria in febrile
patients and to recognize the necessity of a prompt diagnostic
confirmation may lead to unacceptable delay in initiating
treatment.3 Also, microscopical diagnosis is often slow and
inaccurate in nonspecialized laboratories.4 Even in the setting
of specialized centers, malaria cases can be missed as a result
of the low sensitivity of microscopy,5 especially in nonim-
mune travelers receiving chemoprophylaxis. Because of these
limitations, after assessing blood for definite diagnosis, it is
sometimes appropriate to administer a presumptive treat-
ment in febrile patients who do not present obvious symp-
toms or signs specific for another disease. Unfortunately,
there is no evidence-based information to guide clinicians in
treating patients without laboratory confirmation.
Reports on imported malaria generally describe the clinical
presentation of hospitalized patients in centers that special-
ized in tropical medicine,6–15 although no study was specifi-
cally designed to estimate the predictive values of the differ-
ent clinical characteristics. One study in Canada investigated
retrospectively whether the clinical presentation or the labo-
ratory parameters could be used for predicting malaria infec-
tion in febrile travelers. They found symptom duration, tem-
perature, immune status, fever pattern, and presence of en-
larged spleen to be significant variables.16 A study in the
United Kingdom that investigated the causes of imported fe-
ver found thrombopenia and hyperbilirubinemia to be useful
markers of malaria.17
The aim of the present study was to identify useful criteria
to improve the presumptive diagnosis of imported malaria.
We prospectively investigated all patients presenting at a uni-
versity outpatient clinic with a complaint of fever or malaise
after returning from the tropics, and we used a case control
approach to identify significant predictors. Likelihood ratios
(LR) of the different clinical and laboratory parameters were
calculated and posttest probabilities estimated in this popu-
lation of travelers.
MATERIALS AND METHODS
Resident physicians of patients who attended the Medical
Outpatient Clinic, University of Lausanne, Switzerland, with
a complaint of fever or malaise and in whom a malaria test
was performed (blood films for the whole period, plus Para-
Sight-F test for the last 2 years) received a questionnaire to be
filled during the patient follow-up. Because the physicians
were responsible for patient management, they were aware of
the diagnosis at the time the questionnaire was filled out. The
questionnaire included the patient’s demographical data,
travel history, preventive measures against malaria, details on
symptoms and signs at admission, laboratory results, final di-
agnosis, treatment, and outcome. The definition of fever in-
cluded raised temperature or perceived fever malaise com-
prised feelings of cold/warmth, chills, headache, myalgia, or
some combination of these. Entry criteria were based on the
literature and on in-house experience of symptoms indicative
of potential malaria. There was no prerequisite checklist for
the patient’s interview, clinical examination, and laboratory
tests to be performed. However, the institution had informal
guidelines for the diagnosis of fever in returning travelers
including precise and specific questions on travel history and
preventive measures used, detailed clinical examination, and
full blood cell count, including distribution of white cells, he-
moglobin concentration, and hematocrit. Erythrocyte sedi-
mentation rate, creatinine and liver function tests were or-
dered at the discretion of the attending practitioner and were
thus not recorded for all patients.
Although the study was conducted prospectively, we used a
case control approach. A case of malaria was defined as a
patient with at least one of the tests positive for malaria,
irrespective of any other incidental diagnosis. All blood slides
were read by 2 microscopists trained in malaria identification.
When discordant results or species uncertainty occurred, the
slides were read at the reference laboratory in Switzerland
(Swiss Tropical Institute) for confirmation. A control was de-
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fined as a patient with negative tests for malaria on all occa-
sions.
Each variable found to be significantly associated with di-
agnosed malaria in the univariate analysis was included in a
stepwise backward model (significance level for exclusion of
P  0.01) to identify the most important predictors of ma-
laria. The continuous variables, which had demonstrated an
association with malaria in the univariate analysis, were re-
coded as binary variables by using accepted thresholds for
normality. Accepted thresholds were preferred to “optimal”
thresholds that is, thresholds with the best discriminant
power—because the former are more standardized and easier
to use for clinicians. These categorical variables were then
included in the multivariate analysis. Logistic regression
analysis was performed by Stata statistical software (Version
6.0, College Station, TX).
The significant variables associated with malaria in the mul-
tiple logistic regression model were retained and used for the
estimation of the test performance. Likelihood ratios were
calculated by the standard formulas for binary outcomes
[LR+ sensitivity/(1 − specificity); LR− (1 − sensitivity)/
specificity],18 and 95% confidence intervals (CIs) were esti-
mated by Confidence Interval Analysis,19 version 2.0.0. The
pretest probability (prevalence of disease in the sampled
population) multiplied by the LR gave the posttest probabil-
ity. The product of the individuals LR were used when a
combination of 2 independent tests was considered. For con-
tinuous values, LR were modeled as an exponential result of
the test result.20
RESULTS
A total of 336 questionnaires with complete information
were collected from 1990 to 1998. Not all consecutive patients
with fever or malaria were recruited because some doctors
did not fill the questionnaire out adequately, despite repeated
queries. A total of 97 patients (29%) were positive for any
Plasmodium species (3 with the ParaSight-F test only).
Among them, 64 harbored Plasmodium falciparum, including
7 mixed with Plasmodium vivax and 2 undetermined species
considered as falciparum for management purposes; 19 had P.
vivax alone, 9 had Plasmodium ovale, and 5 had Plasmodium
malariae. Among the patients with malaria, 20 (20.6%) were
hospitalized immediately. The rest were managed as outpa-
tients.21
Nonmalaria cases consisted of the following: 21% flulike
syndromes, 18% diarrhea, and 13% respiratory infections
(Table 1). The median age of patients was 33.1 years (range,
16–76 years). A majority (62%) of the patients were men and
had returned from travel to Africa. No children or pregnant
women were included in the study. A total of 94 patients
(28%) were of nonwhite origin; two-thirds were returning
from visiting their home country, and one-third were arriving
in Switzerland for the first time. A total of 89% of falciparum
malaria cases were acquired in Africa, and 8% were acquired
in Asia (32 and 47%, respectively, for cases of vivax malaria).
Prevalence rates of demographic and clinical conditions in the
overall sample of 336 patients are presented in Table 2. Table
3 shows the mean values of continuous variables in the same
groups. The strength of association of each condition with a
diagnosis of malaria and the level of confidence are also
shown in Tables 2 and 3. Thirty of 49 variables tested were
significantly associated with malaria in the univariate analysis.
The backward logistic regression model, which included all
significant variables by univariate analysis, showed that inad-
equate prophylaxis, sweating, no abdominal pain, tempera-
ture  38°C, poor general health, enlarged spleen, hemoglo-
bin < 12 g/dL, leucocytes  10 × 103/L, platelets < 150 ×
103/L, and eosinophiles  5% remained significantly asso-
ciated with malaria (Table 4).
The test performance of the variables found to be signifi-
cantly associated with a diagnosis of malaria in the final
model are presented in Table 5. The highest LR for a positive
test was found for enlarged spleen (assessed clinically) (13.6),
followed by thrombopenia, defined as platelet count < 150 ×
103/L (11.0); the lowest LR for a negative test was for leu-
cocytes  10 × 103/L (0.11). When considering a threshold
of platelets of < 100 × 103/L, the LR rose to 40.7 (95% CI,
11.1–151). The posttest probability for a diagnosis of malaria
was 85% with enlarged spleen [(97/239) × 13.6 5.52; 5.52/(1
+ 5.52)  84.7%] and 82% with thrombopenia (< 150 × 103/
L). When both enlarged spleen and thrombopenia were
combined, the posttest probability was 98%. Figure 1 illus-
trates the probability of malaria as a function of the tempera-
ture and of the platelet count.
DISCUSSION
This study represents what is to our knowledge the first
attempt to prospectively identify the predictors of a diagnosis
of malaria in returning travelers or migrants. Several studies
have been conducted in semi-immune children in endemic
areas to improve the diagnosis of malaria in the absence of
microscopy,22–27 but their conclusions are not readily appli-
cable to nonimmune travelers returning from the tropics with
fever. From the purely descriptive studies in nonimmune trav-
elers or migrants,6–15 we expected inadequate prophylaxis,
measured fever, enlarged spleen, and thrombopenia to be
important predictors of malaria. These parameters were con-
firmed in our study. The association of parasitemia and en-
larged spleen or parasitemia and thrombopenia were strong,
which is in agreement with previous findings.16
In addition, we found poor general health, absence of ab-
dominal pain, sweating, absence of eosinophilia, anemia, and
absence of leucocytosis to be significant predictors of malaria
TABLE 1
Diagnoses found in nonmalaria cases (n 239)
Diagnosis
Proportion,
n (%)
Flulike syndrome 50 (21)
Febrile or bacterial diarrhea 41 (17)
Upper respiratory tract infection 18 (8)
Pneumonia 7 (3)
Urinary tract infection 8 (3)
Angina 6 (3)
Acute hepatitis 5 (2)
Typhoid or paratyphoid fever 4 (2)
Intestinal amebiasis 3 (1)
Dengue fever 2 (1)
Rickettsiosis 2 (1)
Mononucleosis 2 (1)
Cytomegalovirus 2 (1)
Meningitis 1 (0)
Miscellaneous 62 (26)
Unknown 26 (11)
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TABLE 2
Prevalence rate of demographic, clinical, and laboratory conditions in sick patients and strength of association with malaria by univariate analysis
Condition
Overall
prevalence
(336 patients),
n (%)
Prevalence in
malaria cases
(97 patients), n (%)
Prevalence in
nonmalaria cases
(239 patients) n (%)
Odds
ratio
95%
confidence
interval
P
value
Demographic and travel characteristics
Nonwhite origin 94 (28) 39 (40) 55 (23) 2.25 1.36–3.73 0.002
Male sex 207 (62) 74 (76) 133 (56) 2.56 1.50–4.37 0.001
Africa as travel destination 217 (65) 75 (77) 142 (59) 2.33 1.36–4.00 0.002
Travel duration (d) 0.073
1–14 52 (16) 9 (9) 43 (18) Ref – –
15–31 126 (38) 31 (32) 95 (40) 0.64 0.28–1.46 0.29
32–93 59 (18) 23 (24) 36 (15) 0.33 0.14–0.78 0.014
94–365 34 (10) 14 (14) 20 (8) 0.3 0.11–0.81 0.017
> 365 19 (6) 6 (6) 13 (5) 0.45 0.14–1.51 0.2
Immigrants* 46 (14) 14 (14) 32 (13) 0.48 0.18–1.24 0.13
No insectifuge 296 (88) 87 (90) 209 (87) 1.25 0.59–1.50 0.63
No bed nets 252 (75) 71 (73) 181 (76) 0.88 0.51–1.56 0.73
No protective clothing 242 (72) 83 (86) 159 (67) 2.98 1.59–5.58 0.001
No repellent use 221 (66) 75 (77) 146 (61) 2.17 1.26–3.73 0.005
Inadequate prophylaxis 207 (62) 81 (84) 126 (53) 4.54 2.51–8.22 < 0.001
Symptoms
Fever 293 (87) 93 (96) 200 (84) 4.53 1.57–13.1 0.005
Chills 196 (58) 75 (77) 121 (51) 3.32 1.94–5.70 < 0.001
Sweating 177 (53) 66 (68) 111 (46) 2.46 1.49–4.03 < 0.001
Malaise 124 (37) 42 (43) 82 (34) 1.46 0.90–2.37 0.12
Headache 225 (67) 78 (80) 147 (62) 2.57 1.46–4.52 0.001
Myalgia 182 (54) 67 (69) 115 (48) 2.41 1.46–3.97 0.001
Nausea 108 (32) 37 (38) 71 (30) 1.46 0.89–2.39 0.13
Vomiting 56 (17) 21 (22) 35 (15) 1.61 0.88–2.94 0.12
Diarrhea 113 (34) 24 (25) 89 (37) 0.55 0.33–0.94 0.029
Bloody stools 14 (4) 4 (4) 10 (4) 0.98 0.30–3.22 0.98
Abdominal pain 95 (28) 18 (19) 77 (32) 0.48 0.27–0.86 0.013
Signs
Temperature  38°C 114 (34) 55 (57) 59 (25) 4.00 2.43–6.57 < 0.001
Poor general health 49 (15) 29 (30) 20 (8) 4.67 2.48–8.78 < 0.001
Pallor 51 (15) 27 (28) 24 (10) 3.46 1.87–6.37 < 0.001
Jaundice 17 (5) 11 (11) 6 (3) 4.97 1.78–13.8 0.002
Dehydration 35 (10) 17 (18) 18 (8) 2.61 1.28–5.31 0.008
Enlarged liver 9 (3) 3 (3) 6 (3) 1.24 0.30–5.06 0.77
Enlarged spleen 26 (8) 22 (23) 4 (2) 17.2 5.76–51.6 < 0.001
* Immigrants are defined as migrants living in Switzerland without a recent visit to an endemic area.
TABLE 3
Means of demographic, clinical, and laboratory values (continuous variables) in sick patients and strength of association with malaria by
univariate analysis
Condition
Available
data no.
Overall
mean
Malaria cases
(mean ± SD)
Nonmalaria cases
(mean ± SD)
Odds
ratio
95%
Confidence
interval
P
value
Age (y) 336 33.1 33.1 ± 10.2 33.1 ± 11.0 0.99 0.98–1.02 0.95
Duration of symptoms (d) 336 15.4 8.0 ± 12.8 19.1 ± 82.9 0.99 0.97–1.00 0.12
Signs
Temperature 336 37.6 38.2 ± 1.3 37.4 ± 1.0 1.96 1.57–2.44 < 0.001
Pulse 336 84.4 90 ± 16.5 82 ± 15.5 1.03 1.02–1.05 < 0.001
Systolic pressure 336 125 123 ± 16.1 126 ± 15.4 0.99 0.97–1.00 0.16
Diastolic pressure 336 80 76 ± 11.1 81 ± 9.7 0.95 0.93–0.98 < 0.001
Laboratory findings
Hemoglobin 336 141 136 ± 18.7 143 ± 14.5 0.97 0.96–0.99 0.001
Hematocrit 336 42.7 41.0 ± 5.5 43.4 ± 4.2 0.90 0.85–0.95 < 0.001
Erythrocytes 336 4.81 4.65 ± 0.7 4.88 ± 0.5 0.48 0.31–0.75 0.001
Platelets 336 215 142 ± 82.2 244 ± 75.4 0.98 0.98–0.99 < 0.001
Leucocytes 336 7.88 5.96 ± 2.2 8.66 ± 4.6 0.73 0.65–0.81 < 0.001
SR 147 18 25 ± 20.9 15 ± 20.9 1.02 1.00–1.04 0.014
Creatinine 184 92 95 ± 17.1 90 ± 24.4 1.01 0.99–1.02 0.16
Bilirubin 72 19.4 24.5 ± 13.4 14.5 ± 17.8 1.05 1.01–1.09 0.017
Gamma-Glutamyl Transpepridase 138 46.0 45.7 ± 42.8 46.2 ± 69.4 0.99 0.99–1.01 0.96
Glutamic Oxaloacetic Transaminase 180 58.1 31.9 ± 15.3 72.2 ± 274 0.99 0.99–1.00 0.40
Glutamic Pyruvic Transaminase 180 70.7 35.0 ± 27.7 89.9 ± 419 0.99 0.99–1.00 0.41
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in the final multivariate model. One may argue that poor
general health is subjective and thus is of little clinical value.
Complementary analysis (data not shown) showed, however,
that this criterion was associated with several more objective
clinical signs (temperature, diastolic pressure); it may thus
still be of some help in diagnosis establishment and manage-
ment. Elevated white blood cell count is usually considered to
be an indication of bacterial infection; it is also a criterion for
severe malaria28 and is even a prognostic factor for fatal out-
come.29 We infer from our data that it is rarely found in mild
or moderate malaria, a condition that is usually encountered
in the general practice of an outpatient clinic.21 Even if en-
larged spleen, thrombopenia, and normal white blood cell
count were strong predictors of malaria in our sample, they
are also characteristic of a number of other diagnoses of fever
in returning travelers, especially typhoid fever.
One limitation of the study is that the history-taking and
the clinical examination may have not been performed the
same way in the patients with malaria and in controls without
malaria because the clinician may have searched for symp-
toms and signs specific to the diagnosis he or she thought was
the most probable. Because the doctors knew that the study
was focused on malaria, they might have placed more empha-
sis on cases of malaria. But although this criticism may be true
for the analysis of symptoms and signs, it is certainly irrel-
evant for laboratory values. The selection bias, which is re-
flected by the high prevalence of malaria (29%) in our
sample, is, however, unlikely to have led to a bias in the
estimation of the LRs, the key information provided by the
present study, because the latter is based on sensitivity and
specificity rates that are independent of the prevalence.
The study is not observational and therefore provides no
indication on the respective incidence of diseases in returning
travelers. However, we believe that the type of patients re-
cruited is representative of the traveling population who at-
tends a nonspecialized outpatient clinic. This sample is close
to the one that visits general practitioners for fever upon
return from the tropics. We are therefore confident that the
results of the LRs (and not of the test probabilities) can be
generalized to adults belonging to this entire population. The
LR estimated from our study can also be used for the calcu-
lation of test probabilities in an emergency department of a
hospital, as long as the prevalence of malaria, available from
the hospital statistics, is known in each setting. On the other
hand, caution should be taken when applying these results to
other populations, especially children, in whom malaria often
presents with gastrointestinal symptoms or signs.30
In developed countries, the recommendations—to perform
a parasitological examination in all febrile patients returning
from a malaria-endemic area and to initiate a specific treat-
ment as soon as the diagnosis of malaria is confirmed—are
not always followed. Parasitology results are often delayed or
equivocal, especially in nonspecialized centers. Also, because
of the low pyrogenic threshold in nonimmune patients and
the frequent use of chemoprophylaxis, parasite densities are
often low; because the sensitivity of microscopy is low in these
conditions, the confirmation of the diagnosis cannot be made
early in the course of the disease. In the meantime, the patient
can develop complications that may be fatal.
The estimation of the test’s performance outside a blood
slide examination to diagnose malaria can be seen as an aid
for the practitioner, allowing him/her to decide on the rel-
evance of providing presumptive malaria treatment. Given a
particular combination of test results (presence or absence of
symptoms or signs, laboratory values) in a patient, how likely
is the result to be malaria compared with nonmalaria? A LR
of 14 for enlarged spleen tells us that this sign is 14 times more
likely in patients with malaria than in the patients without
malaria; the constellation of enlarged spleen plus thrombope-
nia is 154 (14 × 11) more likely in patients with malaria than
in patients without malaria. More interesting is the estimation
of the posttest probabilities (positive predictive values using
Bayes’ theorem), which are 85% for enlarged spleen, 82% for
thrombopenia, and 98% for the combination of both.
One may argue that such an estimation is of little value
because of its dependence on the prevalence of the disease in
the sampled population (pretest probability). This is true for
TABLE 4
Strength of association with malaria of the significant variables by
multivariate analysis
Condition
Odds
ratio
95% Confidence
interval
P
value
Inadequate prophylaxis 4.65 1.96–11.1 0.001
Sweating 2.13 1.03–4.44 0.042
No abdominal pain 4.05 1.50–10.9 0.006
Temperature  38°C 3.45 1.57–7.60 0.002
Poor general health 4.41 1.34–14.5 0.015
Enlarged spleen 7.71 1.87–31.8 0.005
Hemoglobin < 12 g/dL 6.92 1.80–26.5 0.005
Leucocytes  10 × 103/L 19.1 4.15–87.5 < 0.001
Platelets < 150 × 103/L 12.4 5.45–28.2 < 0.001
Eosinophils  5% 4.68 1.18–18.5 0.028
TABLE 5
Test performance of the predictors of malaria*
Condition
Sensitivity,
% (95% CI)
Specificity,
% (95% CI)
Likelihood ratio for
positive test (95% CI)
Likelihood ratio for
negative test (95% CI)
Inadequate prophylaxis 84 (74–90) 47 (41–54) 1.6 (1.4–1.8) 0.35 (0.22–0.54)
Sweating 68 (58–77) 54 (47–60) 1.5 (1.2–1.8) 0.60 (0.43–0.80)
No abdominal pain 81 (72–88) 32 (26–39) 1.2 (1.0–1.4) 0.58 (0.36–0.89)
Temperature  38°C 57 (46–67) 75 (69–81) 2.3 (1.7–3.0) 0.58 (0.45–0.72)
Poor general health 30 (21–40) 92 (87–95) 3.6 (2.1–6.0) 0.77 (0.66–0.86)
Enlarged spleen 23 (15–33) 98 (96–99.5) 13.6 (5.0–36.8) 0.79 (0.69–0.86)
Hemoglobin < 12 g/dL 16 (9–25) 97 (93–98) 4.6 (2.1–10.3) 0.88 (0.79–0.94)
Leucocytes  10 × 103/L 97 (91–99) 27 (22–33) 1.3 (1.2–1.5) 0.11 (0.04–0.33)
Platelets < 150 × 103/L 60 (49–70) 95 (91–97) 11.0 (6.4–19.1) 0.43 (0.33–0.53)
Eosinophils < 5% 95 (88–98) 12 (8–17) 1.1 (1.0–1.2) 0.43 (0.17–1.02)
* 95% CI  95% confidence interval.
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predictive values calculated from 2 × 2 contingency tables.
The use of LRs allows to estimate predictive values in popu-
lations of patients with different prevalence rates of disease.
For example, a patient returning from the tropics with fever
or malaise (as defined in the present study) had a pretest
probability of 29% (97 of 336); adding an enlarged spleen
allowed us to estimate a posttest probability of 85%. If this
patient had been selected from a sample of patients drawn
from a general practice with a prevalence of 10%, the posttest
probability would have been 60%. The LRs available from
our analysis thus provide the clinician with some evidence-
based information that allows him/her to estimate the prob-
ability of a certain patient having malaria.
It is obvious that the concept of “therapeutic threshold”
must be assessed at this stage. Deciding at what level of prob-
ability a presumptive treatment should be envisaged, or even
strongly advised, is arbitrary. We believe that a posttest prob-
ability of > 80% should lead to the administration of pre-
sumptive treatment against malaria. Some may argue that it
would be wiser to wait for another 12 hours and then repeat
a parasitologic examination. Besides helping the clinician de-
cide whether or not to provide treatment, the estimation of
posttest probabilities also allows the clinician to decide on the
relevance of performing additional investigations to identify
the cause of the disease. If the clinician is reluctant to provide
antimalarial treatment in the absence of documented Plasmo-
dium parasites even though the posttest probability is > 90%,
he/she should at least refrain from performing expensive se-
rologies. Rather, the clinician should wait for the results of an
additional blood slide examination performed some hours
later.
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